- Stocks
- Healthcare
- NASDAQ: PGEN

Price (delayed)

$5.41

Market cap

$1.12B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.76

Enterprise value

$1.27B

PGEN's equity has surged by 160% since the previous quarter and by 100% year-on-year

PGEN's quick ratio has soared by 110% YoY and by 82% from the previous quarter

PGEN's gross margin is up by 14% YoY but it is down by 5% from the previous quarter

PGEN's gross profit is up by 14% year-on-year but it is down by 10% since the previous quarter

Precigen's revenue has decreased by 5% from the previous quarter

What are the main financial stats of PGEN

Market
Valuations
Earnings

Shares outstanding

206.41M

Market cap

$1.12B

Enterprise value

$1.27B

Price to earnings (P/E)

N/A

Price to book (P/B)

6.37

Price to sales (P/S)

10.7

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

13.01

Revenue

$97.85M

EBIT

-$113.67M

EBITDA

-$97.44M

Free cash flow

-$63.31M

Per share
Balance sheet
Liquidity

EPS

-$0.76

Free cash flow per share

-$0.33

Book value per share

$0.85

Revenue per share

$0.51

TBVPS

$1.51

Total assets

$406.98M

Total liabilities

$232.19M

Debt

$184.12M

Equity

$174.8M

Working capital

$118.88M

Debt to equity

1.05

Current ratio

5.71

Quick ratio

5.03

Net debt/EBITDA

-1.61

Margins
Efficiency
Dividend

EBITDA margin

-99.6%

Gross margin

43.9%

Net margin

-134.7%

Operating margin

-80.6%

Return on assets

-37.2%

Return on equity

-150.6%

Return on invested capital

-31%

Return on capital employed

-29.8%

Return on sales

-116.2%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Precigen stock price performed over time

Intraday

-2.7%

1 week

-3.39%

1 month

-18.03%

1 year

21.57%

YTD

-46.96%

QTD

-17.02%

How have Precigen's revenue and profit performed over time

Revenue

$97.85M

Gross profit

$42.99M

Operating income

-$78.88M

Net income

-$131.84M

Gross margin

43.9%

Net margin

-134.7%

PGEN's net income has surged by 58% year-on-year and by 23% since the previous quarter

Precigen's net margin has soared by 58% YoY and by 19% from the previous quarter

PGEN's operating margin is up by 39% YoY and by 4.2% from the previous quarter

Precigen's operating income has increased by 39% YoY and by 9% from the previous quarter

What is Precigen's growth rate over time

What is Precigen stock price valuation

P/E

N/A

P/B

6.37

P/S

10.7

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

13.01

Precigen's EPS has surged by 63% YoY and by 25% QoQ

PGEN's equity has surged by 160% since the previous quarter and by 100% year-on-year

PGEN's P/B is 60% below its last 4 quarters average of 16.0 and 10% below its 5-year quarterly average of 7.1

Precigen's revenue has decreased by 5% from the previous quarter

PGEN's P/S is 3.9% above its 5-year quarterly average of 10.3 but 3.6% below its last 4 quarters average of 11.1

How efficient is Precigen business performance

Precigen's return on sales has surged by 62% YoY and by 21% QoQ

The ROIC has soared by 53% YoY and by 26% from the previous quarter

PGEN's return on equity is up by 42% since the previous quarter and by 21% year-on-year

The ROA has grown by 38% YoY and by 23% from the previous quarter

What is PGEN's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for PGEN.

How did Precigen financials performed over time

The company's total assets is 75% higher than its total liabilities

PGEN's current ratio has surged by 113% year-on-year and by 61% since the previous quarter

PGEN's quick ratio has soared by 110% YoY and by 82% from the previous quarter

Precigen's debt is 5% more than its equity

PGEN's equity has surged by 160% since the previous quarter and by 100% year-on-year

PGEN's debt to equity has plunged by 63% YoY and by 61% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.